3,094 Shares in Molina Healthcare (NYSE:MOH) Purchased by Pzena Investment Management LLC

Pzena Investment Management LLC bought a new position in Molina Healthcare (NYSE:MOH) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,094 shares of the company’s stock, valued at approximately $251,000.

Other hedge funds have also recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System lifted its holdings in Molina Healthcare by 2.8% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 24,447 shares of the company’s stock worth $1,985,000 after buying an additional 669 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Molina Healthcare by 40.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after purchasing an additional 690 shares during the last quarter. Meadow Creek Investment Management LLC increased its position in shares of Molina Healthcare by 22.9% in the 4th quarter. Meadow Creek Investment Management LLC now owns 5,404 shares of the company’s stock worth $414,000 after purchasing an additional 1,008 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Molina Healthcare by 12.4% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 10,067 shares of the company’s stock worth $772,000 after purchasing an additional 1,109 shares during the last quarter. Finally, ING Groep NV increased its position in shares of Molina Healthcare by 23.2% in the 4th quarter. ING Groep NV now owns 6,634 shares of the company’s stock worth $509,000 after purchasing an additional 1,248 shares during the last quarter.

Shares of MOH stock traded up $0.97 during trading hours on Friday, reaching $88.06. 33,012 shares of the stock traded hands, compared to its average volume of 1,222,306. The firm has a market capitalization of $5.23 billion, a P/E ratio of 157.40, a P/E/G ratio of 1.34 and a beta of 1.20. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.36 and a quick ratio of 1.36. Molina Healthcare has a 1-year low of $84.63 and a 1-year high of $85.22.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Monday, February 12th. The company reported $0.34 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.11. Molina Healthcare had a negative net margin of 2.46% and a positive return on equity of 20.08%. The firm had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.96 billion. sell-side analysts predict that Molina Healthcare will post 4.63 EPS for the current fiscal year.

In other Molina Healthcare news, Director John C. Molina sold 62,420 shares of the stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $72.13, for a total value of $4,502,354.60. Following the completion of the sale, the director now directly owns 393,410 shares of the company’s stock, valued at approximately $28,376,663.30. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John C. Molina sold 20,741 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $72.36, for a total transaction of $1,500,818.76. Following the completion of the sale, the director now directly owns 393,410 shares of the company’s stock, valued at $28,467,147.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 87,061 shares of company stock worth $6,305,956. 0.65% of the stock is currently owned by company insiders.

Several research firms have recently weighed in on MOH. Zacks Investment Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $96.00 target price for the company in a research report on Tuesday, April 17th. Morgan Stanley boosted their price objective on shares of Molina Healthcare from $91.00 to $100.00 and gave the company an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann boosted their price objective on shares of Molina Healthcare from $100.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, March 28th. Piper Jaffray upped their target price on shares of Molina Healthcare to $92.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 20th. Finally, Jefferies Group restated a “hold” rating and issued a $80.00 target price on shares of Molina Healthcare in a research report on Wednesday, February 14th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Molina Healthcare presently has an average rating of “Hold” and a consensus price target of $80.92.

Molina Healthcare Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply